TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test
At DNA Labs UAE, we offer the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test. This test helps in the diagnosis of a genetic disorder that affects the heart muscle known as Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 (ARVC1).
Test Details
ARVC1 is characterized by abnormal heart rhythms (arrhythmias) and the replacement of normal heart muscle tissue with fatty or fibrous tissue in the right ventricle. The TGFB3 gene, also known as Transforming Growth Factor Beta 3, is one of the genes associated with ARVC1. Mutations in this gene can lead to the development of the condition.
The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test uses Next-Generation Sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes. In the context of ARVC1, NGS can be used to identify mutations in the TGFB3 gene, as well as other genes known to be associated with the condition.
Test Components and Price
The cost of the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test is AED 4400.0. The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
The report for the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test is typically delivered within 3 to 4 weeks. The test is conducted using NGS technology.
Test Type and Doctor
The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is performed by a cardiologist in the Genetics department.
Pre Test Information
Before undergoing the TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the condition.
Test Procedure
The TGFB3 Gene Arrhythmogenic Right Ventricular Cardiomyopathy Type 1 Genetic Test involves obtaining a DNA sample from the individual being tested. This is usually done through a blood or saliva sample. The DNA sample is then sequenced using NGS technology to identify any mutations or variations in the TGFB3 gene.
Benefits of Genetic Testing
Genetic testing for ARVC1, including the TGFB3 gene, can be beneficial for individuals with a family history of the condition or those who have symptoms suggestive of ARVC1. It can help with early diagnosis, risk assessment, and management of the condition.
Genetic Counseling
Before and after undergoing genetic testing, it is often recommended to seek genetic counseling. This allows for a discussion of the implications of the test results and any potential treatment options or preventive measures.
| Test Name | TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGFB3 Gene Arrhythmogenic right ventricular cardiomyopathy type 1 NGS Genetic DNA Test gene TGFB3 |
| Test Details | Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVC1) is a genetic disorder that affects the heart muscle. It is characterized by abnormal heart rhythms (arrhythmias) and the replacement of normal heart muscle tissue with fatty or fibrous tissue in the right ventricle. The TGFB3 gene, also known as Transforming Growth Factor Beta 3, is one of the genes associated with ARVC1. Mutations in this gene can lead to the development of the condition. NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes. In the context of ARVC1, NGS can be used to identify mutations in the TGFB3 gene, as well as other genes known to be associated with the condition. A TGFB3 gene NGS genetic test involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the TGFB3 gene. The results of the test can help confirm a diagnosis of ARVC1 and provide information about the specific genetic variant present. Genetic testing for ARVC1, including the TGFB3 gene, can be beneficial for individuals with a family history of the condition or those who have symptoms suggestive of ARVC1. It can help with early diagnosis, risk assessment, and management of the condition. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the results and any potential treatment options or preventive measures. |
